MPX International Corp
CNSX:MPXI
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CA |
M
|
MPX International Corp
CNSX:MPXI
|
721.6k CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
984.9B USD |
Loading...
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
525.1B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
273.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
207.6B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
218.5B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
272.2B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.7T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
145.1B USD |
Loading...
|
Market Distribution
| Min | -4 710 029.9% |
| 30th Percentile | -65.8% |
| Median | -2.4% |
| 70th Percentile | 11% |
| Max | 71 100% |
Other Profitability Ratios
MPX International Corp
Glance View
MPX International Corp. is a multinational cannabis company. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-02-04. The firm operates through three segments: Canada, Europe/Africa, and Asia Pacific. The Canada segment’s principal business activities consist of production and sale of cannabis, video learning and engagement, and patient counselling and referral services. The Europe/Africa segment’s principal business activities consist of production and sale of cannabis and hemp related products. The Asia-Pacific segment’s principal business activities consist of production and sale of cannabis. The firm has a portfolio of brands, including holyweed, beleaf, salus, mpx, canveda, spartan, and strain rec.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
Over the last 3 years, MPX International Corp’s Operating Margin has increased from -882.5% to -240.1%. During this period, it reached a low of -948.8% on Dec 31, 2019 and a high of -199.4% on Sep 30, 2021.